Andrej Pešić, Vojin Vuković, Sofija Kozarac, V. Otašević, Tamara Bibić, B. Mihaljević, D. Antić
{"title":"T细胞/组织细胞丰富的大B细胞淋巴瘤并发嗜血细胞淋巴组织细胞增多症的独特表现:病例报告和文献综述","authors":"Andrej Pešić, Vojin Vuković, Sofija Kozarac, V. Otašević, Tamara Bibić, B. Mihaljević, D. Antić","doi":"10.5937/jomb0-48290","DOIUrl":null,"url":null,"abstract":"\nHemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory disorder characterized by dysfunction of NK cells and cytotoxic lymphocytes. We present a rare case of a patient diagnosed with HLH who presented with persistent fever during treatment for refractory T-cell/histiocyte-rich large B-cell lymphoma (TCHRBCL), highlighting the challenges of managing HLH in the context of refractory lymphoma. According to our review of the literature, this is the first case of HLH that developed several months into treatment for refractory TCHRBCL and not in close temporal relation to lymphoma diagnosis.","PeriodicalId":504309,"journal":{"name":"Journal of Medical Biochemistry","volume":"37 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unique presentation of T-cell/histiocyte-rich large B cell lymphoma complicated with hemophagocytic lymphohistiocytosis: case report and review of the literature\",\"authors\":\"Andrej Pešić, Vojin Vuković, Sofija Kozarac, V. Otašević, Tamara Bibić, B. Mihaljević, D. Antić\",\"doi\":\"10.5937/jomb0-48290\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\nHemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory disorder characterized by dysfunction of NK cells and cytotoxic lymphocytes. We present a rare case of a patient diagnosed with HLH who presented with persistent fever during treatment for refractory T-cell/histiocyte-rich large B-cell lymphoma (TCHRBCL), highlighting the challenges of managing HLH in the context of refractory lymphoma. According to our review of the literature, this is the first case of HLH that developed several months into treatment for refractory TCHRBCL and not in close temporal relation to lymphoma diagnosis.\",\"PeriodicalId\":504309,\"journal\":{\"name\":\"Journal of Medical Biochemistry\",\"volume\":\"37 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medical Biochemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5937/jomb0-48290\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/jomb0-48290","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
嗜血细胞性淋巴组织细胞增多症(HLH)是一种罕见的、危及生命的高炎症性疾病,其特点是NK细胞和细胞毒性淋巴细胞功能失调。我们介绍了一例罕见的 HLH 患者,该患者在治疗难治性 T 细胞/富组织细胞大 B 细胞淋巴瘤(TCHRBCL)期间出现持续发热,这突显了在难治性淋巴瘤背景下处理 HLH 所面临的挑战。根据我们的文献综述,这是第一例在治疗难治性TCHRBCL数月后出现的HLH,与淋巴瘤诊断的时间关系并不密切。
Unique presentation of T-cell/histiocyte-rich large B cell lymphoma complicated with hemophagocytic lymphohistiocytosis: case report and review of the literature
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory disorder characterized by dysfunction of NK cells and cytotoxic lymphocytes. We present a rare case of a patient diagnosed with HLH who presented with persistent fever during treatment for refractory T-cell/histiocyte-rich large B-cell lymphoma (TCHRBCL), highlighting the challenges of managing HLH in the context of refractory lymphoma. According to our review of the literature, this is the first case of HLH that developed several months into treatment for refractory TCHRBCL and not in close temporal relation to lymphoma diagnosis.